Sinovant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
SHANGHAI and BEIJING, Jan. 3, 2019 /PRNewswire/ -- Sinovant Sciences today announced that Dr. Xinan Chen, Executive Chairman, and Dr. Rae Yuan, President, will present an overview of the business at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
The company's presentation is scheduled to begin at 8:30 a.m. Pacific Time on January 10, 2019 at the Westin St. Francis.
Sinovant is a Chinese biopharmaceutical company dedicated to conducting globally innovative biomedical R&D in China to meet the needs of patients in Greater China and around the world. Sinovant's mission is to develop and commercialize new medicines that address the most pressing public health challenges in China while simultaneously advancing Chinese biopharmaceutical research abroad. For further information, please visit www.sinovant.com.
Xinan Chen, MD
SOURCE Sinovant Sciences
Upcoming Life Sciences Events
- September 2019
- Boston: 9th Annual American Drug Delivery & Formulation Summit
- Malmo: NLS Days 2019
- Boston: Redefining Early Stage Investments (RESI)
Latest company news
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute